Literature DB >> 24424197

Diagnosis and classification of neuromyelitis optica (Devic's syndrome).

Tali Drori1, Joab Chapman2.   

Abstract

Neuromyelitis optica (NMO) is an autoimmune disorder, predominantly characterized by severe optic neuritis (ON) and transverse myelitis (TM). Historically considered a variant of Multiple sclerosis, the discovery that most NMO patients have autoantibodies against aquaporin-4 (AQP4) or NMO-IgG, dramatically changed our understanding of the disease. The finding of NMO-IgG revealed wider array of clinical presentations, including patients with recurrent ON of TM alone, now considered part of the NMO spectrum. Furthermore, symptoms other than optic-spinal involvement and the presence of brain lesions, do not exclude the diagnosis of NMO as traditionally accepted. We present an overview of the epidemiology, clinical manifestations and current diagnostic criteria for NMO and NMO spectrum disorders.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune CNS diseases; Autoimmunity; Diagnostic criteria; NMO-IgG antibodies; Neuromyelitis optica

Mesh:

Substances:

Year:  2014        PMID: 24424197     DOI: 10.1016/j.autrev.2014.01.034

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  15 in total

1.  Macular changes of neuromyelitis optica through spectral-domain optical coherence tomography.

Authors:  Lu Cheng; Jing Wang; Xu He; Xun Xu; Zhen-Fen Ling
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 2.  Neuromyelitis Optica (Devic's Syndrome): an Appraisal.

Authors:  Teresa M Crout; Laura P Parks; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

Review 3.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

4.  STAT4 Polymorphisms are Associated with Neuromyelitis Optica Spectrum Disorders.

Authors:  Ziyan Shi; Qin Zhang; Hongxi Chen; Zhiyun Lian; Ju Liu; Huiru Feng; Xiaohui Miao; Qin Du; Hongyu Zhou
Journal:  Neuromolecular Med       Date:  2017-08-29       Impact factor: 3.843

Review 5.  Transcriptomic Segregation of Human Autoantigens Useful for the Diagnosis of Autoimmune Diseases.

Authors:  Peter D Burbelo; Michael J Iadarola; Ilias Alevizos; Matthew R Sapio
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

6.  Profile of neuromyelitis optica and spectrum disorders in an Indian cohort.

Authors:  Tatiana Koudriavtseva; Rosaria Renna
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

7.  Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.

Authors:  Jing Miao; Doreen E Aboagye; Boris Chulpayev; Lin Liu; Gary Ishkanian; Bangaruraju Kolanuvada; Dariush Alaie; Richard L Petrillo
Journal:  Am J Case Rep       Date:  2018-01-11

Review 8.  Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges.

Authors:  Rosa M Coco-Martin; Salvador Pastor-Idoate; Jose Carlos Pastor
Journal:  Pharmaceutics       Date:  2021-06-11       Impact factor: 6.321

Review 9.  Follicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal Models.

Authors:  Xueli Fan; Chenhong Lin; Jinming Han; Xinmei Jiang; Jie Zhu; Tao Jin
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

10.  Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis.

Authors:  Mengyu Han; You Chen; Luqi Nong; Ziqiang Liu; Lu Hao; Zhijun Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.